Global Patent Index - EP 3782987 A4

EP 3782987 A4 20210519 - BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR

Title (en)

BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR

Title (de)

BENZOPYRAZOLVERBINDUNG ALS RHO-KINASEINHIBITOR

Title (fr)

COMPOSÉ DE BENZO-PYRAZOLE TENANT LIEU D'INHIBITEUR DE LA RHO-KINASE

Publication

EP 3782987 A4 20210519 (EN)

Application

EP 19788388 A 20190418

Priority

  • CN 201810349362 A 20180418
  • CN 201811221303 A 20181019
  • CN 2019083210 W 20190418

Abstract (en)

[origin: EP3782987A1] The invention relates to a benzopyrazole compound used as RHO kinase inhibitor, a pharmaceutical composition and uses thereof for preparing an RHO kinase inhibiting drug, and more specifically to said compound of formula (I-1), a pharmaceutically acceptable salt and isomer thereof.

IPC 8 full level

C07D 231/56 (2006.01); A61K 31/416 (2006.01); A61P 11/00 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/12 (2006.01)

CPC (source: EP US)

A61P 11/00 (2017.12 - EP US); C07D 231/56 (2013.01 - EP US); C07D 401/04 (2013.01 - EP US); C07D 403/04 (2013.01 - EP US); C07D 403/12 (2013.01 - EP US)

Citation (search report)

  • No further relevant documents disclosed
  • See references of WO 2019201297A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

EP 3782987 A1 20210224; EP 3782987 A4 20210519; CN 112020496 A 20201201; CN 112020496 B 20230428; JP 2021522201 A 20210830; JP 7187575 B2 20221212; US 11345678 B2 20220531; US 2021371393 A1 20211202; WO 2019201297 A1 20191024

DOCDB simple family (application)

EP 19788388 A 20190418; CN 2019083210 W 20190418; CN 201980026510 A 20190418; JP 2020557966 A 20190418; US 201917047840 A 20190418